Clinical Trials Browser

Interventional × Prostatic Neoplasms × apatorsen × Clear all

NCT01681433 2022-07-11

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Phase 2 Terminated

72 enrolled 14 charts

Prostatic Neoplasms